• Submitted by: admin
• Science and Technology
• 11 / 15 / 2006

The German scientist, elected Honorary President of the International Congress Biotechnology 2006, that takes place in Havana, recognized the work of his counterparts of the Center for Genetic Engineering and Biotechnology (CIGB), and other scientific institutions in Cuba.

In statements to press, Huber, who devotes his work to the study of the three-dimensional structure of the molecules and the proteins, expressed his intention to carry out joint researches on the self-immune diseases with the Cuban scientists.

He also explained that knowing such aggressive structures would make possible the design of new drugs to cure or soothe the ailments that might be the arthritis, the degenerative osteoarthritis and the lupus erythematosus.

Robert Huber highlighted the advances of Cubas CIGG in developing the dengue vaccine and predicted the successes of the immunogen to thwart an illness that affects millions of people, mainly in the Americas.

The Nobel Prize winner told AIN, that the discovery of the Haemofillus Influenzae vaccine, the only one of its kind in the world, and the Island shares with other countries was a great success for Cuba.